Prognostic value of initial magnetic resonance imaging growth rates for World Health Organization grade II gliomas.
about
Awake surgery for hemispheric low-grade gliomas: oncological, functional and methodological differences between pediatric and adult populations.The role of imaging in the management of adults with diffuse low grade glioma: A systematic review and evidence-based clinical practice guideline.Advanced MRI in the management of adult gliomas.Imaging growth and isocitrate dehydrogenase 1 mutation are independent predictors for diffuse low-grade gliomas.Prolonged response without prolonged chemotherapy: a lesson from PCV chemotherapy in low-grade gliomasA Molecular Predictor Reassesses Classification of Human Grade II/III GliomasImaging of gliomas at 1.5 and 3 Tesla - A comparative study.Dynamic imaging response following radiation therapy predicts long-term outcomes for diffuse low-grade gliomas.Glial progenitor cell recruitment drives aggressive glioma growth: mathematical and experimental modelling.Neurosurgical management of adult diffuse low grade gliomas in Canada: a multi-center surveyA mathematical modelling tool for predicting survival of individual patients following resection of glioblastoma: a proof of principleFrom patient-specific mathematical neuro-oncology to precision medicineVelocity of tumor spontaneous expansion predicts long-term outcomes for diffuse low-grade gliomas.Quantitative metrics of net proliferation and invasion link biological aggressiveness assessed by MRI with hypoxia assessed by FMISO-PET in newly diagnosed glioblastomasPrognostic significance of imaging contrast enhancement for WHO grade II gliomas.The challenge to remove diffuse low-grade gliomas while preserving brain functions.Quantitative morphological magnetic resonance imaging follow-up of low-grade glioma: a plea for systematic measurement of growth rates.The "onco-functional balance" in surgery for diffuse low-grade glioma: integrating the extent of resection with quality of life.A mathematical model describes the malignant transformation of low grade gliomas: Prognostic implications.Surgery of insular and paralimbic diffuse low-grade gliomas: technical considerations.'Low grade glioma': an update for radiologists.Diffuse low-grade glioma: a review on the new molecular classification, natural history and current management strategies.A generative approach for image-based modeling of tumor growth.Quantifying the role of angiogenesis in malignant progression of gliomas: in silico modeling integrates imaging and histologyPrognostic significance of growth kinetics in newly diagnosed glioblastomas revealed by combining serial imaging with a novel biomathematical model.The Clinical Value of PET with Amino Acid Tracers for Gliomas WHO Grade IIIs the volume of low-grade glioma measurable and is it clinically relevant?Is a prospective trial necessary to suggest a clinical relevance?Supratentorial WHO grade II glioma invasion: a morphologic study using sequential conventional MRI.Awake surgery for incidental WHO grade II gliomas involving eloquent areas.The silent phase of diffuse low-grade gliomas. Is it when we missed the action?Neoadjuvant chemotherapy may optimize the extent of resection of World Health Organization grade II gliomas: a case series of 17 patients.Oedema-based model for diffuse low-grade gliomas: application to clinical cases under radiotherapy.Increased growth rate of a WHO grade I ganglioglioma during pregnancy.Improving the time-machine: estimating date of birth of grade II gliomas.Surgical resection versus watchful waiting in low-grade gliomas.Effects of slice thickness and head rotation when measuring glioma sizes on MRI: in support of volume segmentation versus two largest diameters methods.1P19Q loss but not IDH1 mutations influences WHO grade II gliomas spontaneous growth.Modeling the dynamics of oligodendrocyte precursor cells and the genesis of gliomas.Evidence for the genesis of WHO grade II glioma in an asymptomatic young adult using repeated MRIs.
P2860
Q30245146-9D04FD3B-5281-4A8F-8D1E-62E4703CCD8CQ31016200-CED136B9-35B0-462A-9E18-EA4A8A6D17CEQ31139548-01A641CE-CECD-4152-AE6A-F79F400F1CE0Q33894486-DCDBE1FF-DAAB-4A1D-B6D6-1B72B33589EBQ34480589-FA0C23D1-09BC-4658-B9CF-2B9E86CFF8EFQ34785423-DDD48AED-E56C-4F6F-AD6F-380E2BF47034Q35788981-D54C4468-6908-4456-96E0-867B296FBE83Q35845266-0D01492B-D4CB-4EB8-B245-A63683796842Q36065454-DADFDAF1-5BB6-4B3C-961A-A5ADF13C05BCQ36381656-E7A260EC-0243-45F6-8B66-88A491324638Q36608763-4BEFB87B-47B1-467B-9BD7-807FF9C212DFQ36733380-DA26EB74-9C99-4B48-B428-5E85D8AE8F0CQ36792738-BCA1CCC4-D414-4EBF-9979-BF66B903F09EQ37140172-04910B66-78DB-4811-91C1-1C5AA43A8CBDQ37284308-21075126-1E59-4C49-9E38-B678B8927110Q37978808-A32F95B9-7874-430B-AB64-D81158FCAFC8Q38016287-69D25632-77C2-413F-B67F-15A0BEC02798Q38085253-582CA4CE-1E3F-4F98-95B3-0771C8AADB50Q38649268-62B81140-4A21-42EC-ACA8-E4610FDDD96AQ38830322-69D5704C-6333-4B9C-83F9-F7F0E587566FQ39031402-8EBC54F4-E146-46B5-8EEC-D963496B9627Q39159242-9B003700-D660-4BD7-A220-82167AACD158Q39768242-2DEE27F8-7DB5-49AD-B7E2-D01D92218F60Q42239810-3ECC9363-B8D5-4A37-9C28-3873D06B4F65Q42434135-E2C474C5-0E7A-4D91-891B-9DA0632884CCQ42734117-BBEF2B97-278B-49B0-966C-A799641E01A4Q42734360-AF8CF02D-0266-41A3-AAF6-DF2F2CEAD499Q42804581-8DD28290-31C0-4BAB-8AB7-2DA97253167AQ43427066-3D9A5FF8-461A-4895-909D-E82CC6886DA6Q43874653-EA39184C-A6C4-480F-AFDC-E87EC02D1B2CQ44065164-F8340AA6-D4B8-4DE6-9EC2-373132AB0FDBQ44347317-FC721959-E5B6-4BA4-B78E-51A35FF1BBA4Q44949016-8BCA2F97-6B02-4C11-8C75-0FE8E01042C5Q45216237-C23699D5-D25C-4201-97BF-FF980374C415Q47338276-D6D1D350-8250-4504-8CD9-DE520894CD09Q47379204-B5518976-71ED-4D14-A3B2-A835D7FDDC3FQ48168989-5B144FF7-EB71-407A-A766-BA5709FCCF02Q48627896-14195C4D-A4A5-4956-BAFC-E91C747196B0Q52625704-ACEF332C-7E48-456A-BA90-8104AD1CA7DCQ53291835-E6080262-E155-43E5-B814-E6DC994ED75E
P2860
Prognostic value of initial magnetic resonance imaging growth rates for World Health Organization grade II gliomas.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Prognostic value of initial ma ...... Organization grade II gliomas.
@en
Prognostic value of initial ma ...... Organization grade II gliomas.
@nl
type
label
Prognostic value of initial ma ...... Organization grade II gliomas.
@en
Prognostic value of initial ma ...... Organization grade II gliomas.
@nl
prefLabel
Prognostic value of initial ma ...... Organization grade II gliomas.
@en
Prognostic value of initial ma ...... Organization grade II gliomas.
@nl
P2093
P356
P1433
P1476
Prognostic value of initial ma ...... Organization grade II gliomas.
@en
P2093
Damien Galanaud
Emmanuel Mandonnet
Hugues Duffau
Laurent Capelle
Luc Taillandier
Michèle Kujas
Rémy Guillevin
P304
P356
10.1002/ANA.20946
P50
P577
2006-09-01T00:00:00Z